NewYork-Presbyterian Health reduced its workforce by 2%, or about 1,000 employees. Nurses voiced concerns that the layoffs unnecessarily harmed care.

CEO Keith Gottesdiener will be replaced by Prime's CFO as the company cuts 25% of its workforce and deprioritizes its lead ...

The Cambridge biotech's wild ambitions for a powerful gene editing technology sank as the biotech market slumped.

This comprehensive report offers an overview of clinical trials, featuring data by region, country, phase, and sponsor type. Unlock competitive advantages with detailed analysis of ongoing trials and ...